Remimazolam versus propofol for sedation in gastrointestinal endoscopy and colonoscopy within elderly patients: a meta-analysis of randomized controlled trials
Wania Ahmer,Sahar Imtiaz,Daniyal Muhammad Alam,Khadija Ahmed,Barka Sajid,Juvairia Yousuf,Sunny Asnani,Muhammad Ahmed Ali Fahim,Rahmeen Ali,Marium Mansoor,Muhammad Talha Safdar,Muhammad Umair Anjum,Muhammad Hasanain,Muhammad Omar Larik
DOI: https://doi.org/10.1007/s00228-024-03624-6
2024-01-24
European Journal of Clinical Pharmacology
Abstract:Propofol has become the sedative of choice for endoscopy and colonoscopy. However, it has shown associations with various adverse effects, specifically in the geriatric population. In contrast, remimazolam is a novel benzodiazepine, demonstrating a superior clinical safety profile. Hence, this systematic review and meta-analysis aims to clarify the efficacy and safety of remimazolam versus propofol in elderly patients (≥ 60 years) undergoing gastrointestinal endoscopic and colonoscopy procedures.
pharmacology & pharmacy
What problem does this paper attempt to address?